Search Results | American Association for Cancer Research

1-20 of 274

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production

Michelle K. Gleason, Michael R. Verneris, Deborah A. Todhunter, Bin Zhang, Valarie McCullar, Sophia X. Zhou, Angela Panoskaltsis-Mortari, Louis M. Weiner, Daniel A. Vallera, Jeffrey S. Miller

Mol Cancer Ther (2012) 11 (12): 2674–2684.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0692

Published: 09 December 2012

View article

Journal Articles

Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens

Matthias Friedrich, Tobias Raum, Ralf Lutterbuese, Markus Voelkel, Petra Deegen, Doris Rau, Roman Kischel, Patrick Hoffmann, Christian Brandl, Joachim Schuhmacher, Peter Mueller, Ricarda Finnern, Melanie Fuergut, Dieter Zopf, Jerry W. Slootstra, Patrick A. Baeuerle, Benno Rattel, Peter Kufer

Mol Cancer Ther (2012) 11 (12): 2664–2673.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0042

Published: 09 December 2012

View article

Journal Articles

BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer

Niranjan Awasthi, Changhua Zhang, Winston Ruan, Margaret A. Schwarz, Roderich E. Schwarz

Mol Cancer Ther (2012) 11 (12): 2644–2653.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0447

Published: 09 December 2012

View article

Includes: Supplementary data

Journal Articles

Development of Gene Expression–Based Score to Predict Sensitivity of Multiple Myeloma Cells to DNA Methylation Inhibitors

Jérôme Moreaux, Thierry Rème, Wim Leonard, Jean-Luc Veyrune, Guilhem Requirand, Hartmut Goldschmidt, Dirk Hose, Bernard Klein

Mol Cancer Ther (2012) 11 (12): 2685–2692.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0721

Published: 09 December 2012

View article

Includes: Supplementary data

Journal Articles

Targeting the Inhibitor of Apoptosis Proteins as a Novel Therapeutic Strategy in Medulloblastoma

Joanna Keating, Maria Tsoli, Andrew R. Hallahan, Wendy J. Ingram, Michelle Haber, David S. Ziegler

Mol Cancer Ther (2012) 11 (12): 2654–2663.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0352

Published: 09 December 2012

View article

Includes: Supplementary data

Journal Articles

Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts

Angela Romanelli, Anderson Clark, Franck Assayag, Sophie Chateau-Joubert, Marie-France Poupon, Jean-Luc Servely, Jean-Jacques Fontaine, Xiaohong Liu, Edward Spooner, Samantha Goodstal, Patricia de Cremoux, Ivan Bièche, Didier Decaudin, Elisabetta Marangoni

Mol Cancer Ther (2012) 11 (12): 2693–2703.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0441-T

Published: 09 December 2012

View article

Includes: Supplementary data

Journal Articles

Targeting KRAS-Mutant Non–Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib

Jaime Acquaviva, Donald L. Smith, Jim Sang, Julie C. Friedland, Suqin He, Manuel Sequeira, Chaohua Zhang, Yumiko Wada, David A. Proia

Mol Cancer Ther (2012) 11 (12): 2633–2643.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0615

Published: 09 December 2012

View article

Includes: Supplementary data

Journal Articles

A Locked, Dimeric CXCL12 Variant Effectively Inhibits Pulmonary Metastasis of CXCR4-Expressing Melanoma Cells Due to Enhanced Serum Stability

Tomonori Takekoshi, Joshua J. Ziarek, Brian F. Volkman, Sam T. Hwang

Mol Cancer Ther (2012) 11 (11): 2516–2525.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0494

Published: 08 November 2012

View article

Includes: Supplementary data

Journal Articles

Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth

Ruchi Bansal, Tushar Tomar, Arne Östman, Klaas Poelstra, Jai Prakash

Mol Cancer Ther (2012) 11 (11): 2419–2428.

DOI: https://doi.org/10.1158/1535-7163.MCT-11-0758

Published: 08 November 2012

View article

Includes: Supplementary data

Journal Articles

O(6)-Methylguanine-DNA Methyltransferase Is a Novel Negative Effector of Invasion in Glioblastoma Multiforme

Manik Chahal, Bassam Abdulkarim, Yaoxian Xu, Marie-Christine Guiot, Jacob C. Easaw, Nicolas Stifani, Siham Sabri

Mol Cancer Ther (2012) 11 (11): 2440–2450.

DOI: https://doi.org/10.1158/1535-7163.MCT-11-0977

Published: 08 November 2012

View article

Includes: Multimedia, Supplementary data

Journal Articles

Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas

Hee-Yeon Cho, Weijun Wang, Niyati Jhaveri, Shering Torres, Joshua Tseng, Michelle N. Leong, David Jungpa Lee, Amir Goldkorn, Tong Xu, Nicos A. Petasis, Stan G. Louie, Axel H. Schönthal, Florence M. Hofman, Thomas C. Chen

Mol Cancer Ther (2012) 11 (11): 2462–2472.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0321

Published: 08 November 2012

View article

Includes: Supplementary data

Journal Articles

Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor–Targeted Therapy

Atul Bedi, Xiaofei Chang, Kimberly Noonan, Vui Pham, Rishi Bedi, Elana J. Fertig, Michael Considine, Joseph A. Califano, Ivan Borrello, Christine H. Chung, David Sidransky, Rajani Ravi

Mol Cancer Ther (2012) 11 (11): 2429–2439.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0101-T

Published: 08 November 2012

View article

Includes: Supplementary data

Journal Articles

Synthetic Lethal Screening with Small-Molecule Inhibitors Provides a Pathway to Rational Combination Therapies for Melanoma

Devin G. Roller, Mark Axelrod, Brian J. Capaldo, Karin Jensen, Aaron Mackey, Michael J. Weber, Daniel Gioeli

Mol Cancer Ther (2012) 11 (11): 2505–2515.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0461

Published: 08 November 2012

View article

Includes: Supplementary data

Journal Articles

Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells

De-Kuan Chang, Jianhua Sui, Shusheng Geng, Asli Muvaffak, Mei Bai, Robert C. Fuhlbrigge, Agnes Lo, Anuradha Yammanuru, Luke Hubbard, Jared Sheehan, James J. Campbell, Quan Zhu, Thomas S. Kupper, Wayne A. Marasco

Mol Cancer Ther (2012) 11 (11): 2451–2461.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0278

Published: 08 November 2012

View article

Includes: Supplementary data

Journal Articles

Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents

Zheng D. Liang, Yan Long, Wen-Bin Tsai, Siqing Fu, Razelle Kurzrock, Mihai Gagea-Iurascu, Fan Zhang, Helen H.W. Chen, Bryan T. Hennessy, Gordon B. Mills, Niramol Savaraj, Macus Tien Kuo

Mol Cancer Ther (2012) 11 (11): 2483–2494.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0580

Published: 08 November 2012

View article

Includes: Supplementary data

Journal Articles

Stromal Platelet-Derived Growth Factor Receptor α (PDGFRα) Provides a Therapeutic Target Independent of Tumor Cell PDGFRα Expression in Lung Cancer Xenografts

David E. Gerber, Puja Gupta, Michael T. Dellinger, Jason E. Toombs, Michael Peyton, Inga Duignan, Jennifer Malaby, Timothy Bailey, Colleen Burns, Rolf A. Brekken, Nick Loizos

Mol Cancer Ther (2012) 11 (11): 2473–2482.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0431

Published: 08 November 2012

View article

Includes: Supplementary data

Journal Articles

8-Amino-Adenosine Activates p53-Independent Cell Death of Metastatic Breast Cancers

Alla Polotskaia, Sandy Hoffman, Nancy L. Krett, Mala Shanmugam, Steven T. Rosen, Jill Bargonetti

Mol Cancer Ther (2012) 11 (11): 2495–2504.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0085

Published: 08 November 2012

View article

Journal Articles

Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer

Chun-Te Chen, Yi Du, Hirohito Yamaguchi, Jung-Mao Hsu, Hsu-Ping Kuo, Gabriel N. Hortobagyi, Mien-Chie Hung

Mol Cancer Ther (2012) 11 (10): 2212–2221.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0180

Published: 09 October 2012

View article

Includes: Supplementary data

Journal Articles

FcRL5 as a Target of Antibody–Drug Conjugates for the Treatment of Multiple Myeloma

Kristi Elkins, Bing Zheng, MaryAnn Go, Dionysos Slaga, Changchun Du, Suzie J. Scales, Shang-Fan Yu, Jacqueline McBride, Ruth de Tute, Andy Rawstron, Andrew S. Jack, Allen Ebens, Andrew G. Polson

Mol Cancer Ther (2012) 11 (10): 2222–2232.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0087

Published: 09 October 2012

View article

Includes: Supplementary data

Journal Articles

Drug Resistance to Inhibitors of the Human Double Minute-2 E3 Ligase Is Mediated by Point Mutations of p53, but Can Be Overcome with the p53 Targeting Agent RITA

Richard J. Jones, Chad C. Bjorklund, Veerabhadran Baladandayuthapani, Deborah J. Kuhn, Robert Z. Orlowski

Mol Cancer Ther (2012) 11 (10): 2243–2253.

DOI: https://doi.org/10.1158/1535-7163.MCT-12-0135

Published: 09 October 2012

View article

Includes: Supplementary data

2 3 4 5

NARROW

Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production

Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens

BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer

Development of Gene Expression–Based Score to Predict Sensitivity of Multiple Myeloma Cells to DNA Methylation Inhibitors

Targeting the Inhibitor of Apoptosis Proteins as a Novel Therapeutic Strategy in Medulloblastoma

Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts

Targeting KRAS-Mutant Non–Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib

A Locked, Dimeric CXCL12 Variant Effectively Inhibits Pulmonary Metastasis of CXCR4-Expressing Melanoma Cells Due to Enhanced Serum Stability

Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth

O(6)-Methylguanine-DNA Methyltransferase Is a Novel Negative Effector of Invasion in Glioblastoma Multiforme

Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas

Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor–Targeted Therapy

Synthetic Lethal Screening with Small-Molecule Inhibitors Provides a Pathway to Rational Combination Therapies for Melanoma

Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells

Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents

Stromal Platelet-Derived Growth Factor Receptor α (PDGFRα) Provides a Therapeutic Target Independent of Tumor Cell PDGFRα Expression in Lung Cancer Xenografts

8-Amino-Adenosine Activates p53-Independent Cell Death of Metastatic Breast Cancers

Targeting the IKKβ/mTOR/VEGF Signaling Pathway as a Potential Therapeutic Strategy for Obesity-Related Breast Cancer

FcRL5 as a Target of Antibody–Drug Conjugates for the Treatment of Multiple Myeloma

Drug Resistance to Inhibitors of the Human Double Minute-2 E3 Ligase Is Mediated by Point Mutations of p53, but Can Be Overcome with the p53 Targeting Agent RITA

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only